Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
BSJ-03-204
Description:
BSJ-03-204 is a drug that is currently in pre-clinical trials for the treatment of cancer. It has been shown to inhibit the target protein, BCR-ABL, which is found in a number of cancers and is responsible for resistance to other drugs. BSJ-03-204 also inhibits proteolysis and increases sensitivity to cancer drugs. This drug may be an advance in the treatment of cancers and could potentially lead to a decrease in drug resistance.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
832.9 g/mol
Formula:
C43H48N10O8
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-ZTD35609 BSJ-03-204
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
